Skip to main content

Select Drug Profiles

Practice Management
Expect the Unexpected: A Role for Behavioral Economics in Understanding the Impact of Cost- Sharing on Emergency Department Utilization
Albert Tzeel, MD, MHSA, CPE, FAAPL, Jack Brown, BA
Stakeholder Perspective
by Alberto M. Colombi, MD, MPH
Read More
Original Research
Effectiveness of Anti-Tumor Necrosis Factor Agents in the Treatment of Rheumatoid Arthritis: Observational Study
Anna D’Souza, PhD, Brian L. Meissner, PharmD, PhD, Boxiong Tang, MD, PhD, Scott McKenzie, MD, Catherine T. Piech, MBA
Stakeholder Perspective
Effectiveness of Anti-TNFs in Patients with RA, and Coverage Considerations
by Matthew Mitchell, PharmD, MBA, FAMCP
Read More
Practice Management
Comparing Medical Cost of Care for Patients with Metastatic Breast Cancer Receiving Taxane Therapy: Claims Analysis
Rex W. Force, PharmD, Brooke A. Pugmire, PharmD, Vaughn L. Culbertson, PharmD
Stakeholder Perspective
Can We Afford Improved Clinical Outcomes?
by Atheer A. Kaddis, PharmD
Read More
Practice Management
Use of Comparative Effectiveness Analysis in Managed Care
Gene Reeder, RPh, PhD, Timothy S. Regan, BPharm, RPh, CPh
Read More
Managed Care Network Survey Highlights
Gene Reeder, RPh, PhD, Timothy S. Regan, BPharm, RPh, CPh
Read More
Healthcare Reform Must Include Multiple Components
Wayne Kuznar
Read More
Revisiting JUPITER: When Is Statin Therapy Cost-Effective?
Read More
Oncologists Cautioned About Use of ESAs
Caroline Helwick
Read More
Conference Highlights AMCP
Cost-Sharing Has Negative Effects on Biologics
Sandy Paton
Read More
Conference Highlights AMCP
Clinical Journals Valuable Source for Formulary Decisions
Sandy Paton
Read More
Page 226 of 244
Results 2251 - 2260 of 2438